Analysts Set Select Medical Holdings Corporation Price Target at $15.63

The healthcare provider faces a mixed outlook from Wall Street analysts.

Apr. 4, 2026 at 5:48am

Got story updates? Submit your updates here. ›

A high-contrast black and white close-up image of the complex machinery and gears inside a modern hospital bed, representing the heavy industrial nature of healthcare technology and infrastructure.The inner workings of the healthcare industry's infrastructure are a critical, if often unseen, component of patient care.Mechanicsburg Today

Shares of Select Medical Holdings Corporation (NYSE:SEM) have received an average 'Hold' recommendation from seven research analysts covering the stock. The analysts have set a 12-month price target of $15.63 on the stock, with one recommending a 'Sell', four a 'Hold', and two a 'Buy' rating.

Why it matters

Select Medical's mixed analyst ratings and price target reflect the challenges facing the healthcare provider as it navigates the evolving landscape of long-term acute care hospitals and inpatient rehabilitation facilities. Investors will be watching to see if the company can execute on its strategic initiatives and deliver improved financial performance.

The details

The analysts' recommendations and price target for Select Medical come after the company reported Q4 2025 earnings that missed consensus estimates. The healthcare provider operates two main business segments - Hospital Division and Outpatient Rehabilitation Division - and has grown through partnerships, joint ventures and acquisitions over the years.

  • Select Medical reported Q4 2025 earnings on February 19, 2026.
  • The company's board authorized a $1 billion share repurchase program on February 19, 2026.

The players

Select Medical Holdings Corporation

A leading provider of specialized healthcare services in the United States, operating long-term acute care hospitals and inpatient rehabilitation facilities.

Royal Bank Of Canada

One of the research firms covering Select Medical, which reaffirmed a 'sector perform' rating and $16.50 price target on the stock.

Wall Street Zen

A research firm that downgraded Select Medical from 'buy' to 'hold' in a recent report.

Zacks Research

A research firm that downgraded Select Medical from 'hold' to 'strong sell' in a recent report.

Weiss Ratings

A research firm that upgraded Select Medical from 'sell (d+)' to 'hold (c-)' in a recent report.

Benchmark

A research firm that downgraded Select Medical from 'buy' to 'hold' in a recent report.

Got photos? Submit your photos here. ›

The takeaway

Select Medical's mixed analyst ratings and price target reflect the challenges facing the company as it navigates the evolving healthcare landscape. Investors will be watching to see if the provider can execute on its strategic initiatives and deliver improved financial performance.